Medical Properties Trust Analyst Ratings
Medical Properties Trust Analyst Ratings
医疗地产信托分析师评级
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | -18.03% | Wells Fargo | → $4 | Downgrades | Equal-Weight → Underweight |
| 09/25/2023 | 104.92% | RBC Capital | → $10 | Reiterates | Outperform → Outperform |
| 08/31/2023 | 84.43% | Mizuho | $18 → $9 | Downgrades | Buy → Neutral |
| 08/22/2023 | 104.92% | Barclays | $12 → $10 | Maintains | Overweight |
| 08/21/2023 | 43.44% | JP Morgan | $9 → $7 | Downgrades | Neutral → Underweight |
| 08/14/2023 | 104.92% | RBC Capital | $12 → $10 | Maintains | Outperform |
| 08/11/2023 | 63.93% | B of A Securities | $9 → $8 | Downgrades | Neutral → Underperform |
| 08/11/2023 | — | Raymond James | Downgrades | Strong Buy → Underperform | |
| 06/23/2023 | 104.92% | Truist Securities | $9 → $10 | Maintains | Hold |
| 04/20/2023 | 84.43% | Wells Fargo | → $9 | Initiates Coverage On | → Equal-Weight |
| 04/19/2023 | 84.43% | Wells Fargo | → $9 | Initiates Coverage On | → Equal-Weight |
| 04/05/2023 | 145.9% | Barclays | $14 → $12 | Maintains | Overweight |
| 04/04/2023 | 207.38% | Keybanc | $16 → $15 | Maintains | Overweight |
| 03/31/2023 | 84.43% | Truist Securities | $8 → $9 | Maintains | Hold |
| 03/29/2023 | 63.93% | Truist Securities | $14 → $8 | Maintains | Hold |
| 03/16/2023 | 104.92% | B of A Securities | → $10 | Downgrades | Buy → Neutral |
| 03/07/2023 | 125.41% | Credit Suisse | → $11 | Reiterates | → Neutral |
| 03/03/2023 | 145.9% | JP Morgan | $14 → $12 | Maintains | Neutral |
| 03/02/2023 | 227.87% | Raymond James | $18 → $16 | Maintains | Strong Buy |
| 02/27/2023 | 186.89% | Barclays | $17 → $14 | Maintains | Overweight |
| 02/24/2023 | 125.41% | Credit Suisse | $13 → $11 | Maintains | Neutral |
| 01/27/2023 | 248.36% | Barclays | $19 → $17 | Maintains | Overweight |
| 01/19/2023 | 227.87% | Keybanc | $18 → $16 | Maintains | Overweight |
| 01/17/2023 | 166.39% | Credit Suisse | $11 → $13 | Maintains | Neutral |
| 12/21/2022 | 125.41% | Credit Suisse | $17 → $11 | Maintains | Neutral |
| 11/14/2022 | 227.87% | B of A Securities | → $16 | Upgrades | Neutral → Buy |
| 10/21/2022 | 289.34% | Barclays | $23 → $19 | Maintains | Overweight |
| 10/04/2022 | 268.85% | RBC Capital | $20 → $18 | Maintains | Outperform |
| 09/22/2022 | 268.85% | Raymond James | $20 → $18 | Maintains | Strong Buy |
| 09/16/2022 | 207.38% | Deutsche Bank | $17 → $15 | Maintains | Hold |
| 08/04/2022 | 371.31% | Barclays | $27 → $23 | Maintains | Overweight |
| 07/29/2022 | 309.84% | Mizuho | $26 → $20 | Maintains | Buy |
| 07/15/2022 | 309.84% | Raymond James | $24 → $20 | Maintains | Strong Buy |
| 07/14/2022 | 248.36% | Credit Suisse | $23 → $17 | Downgrades | Outperform → Neutral |
| 07/13/2022 | 248.36% | Deutsche Bank | $20 → $17 | Maintains | Hold |
| 07/07/2022 | 268.85% | Keybanc | $23 → $18 | Maintains | Overweight |
| 06/30/2022 | 207.38% | Jefferies | $19 → $15 | Maintains | Hold |
| 06/22/2022 | 268.85% | JP Morgan | $24 → $18 | Downgrades | Overweight → Neutral |
| 05/20/2022 | 350.82% | RBC Capital | $25 → $22 | Maintains | Outperform |
| 05/10/2022 | 391.8% | Raymond James | $26 → $24 | Maintains | Strong Buy |
| 05/02/2022 | 371.31% | Credit Suisse | $26 → $23 | Maintains | Outperform |
| 04/27/2022 | 309.84% | Deutsche Bank | $25 → $20 | Maintains | Hold |
| 04/27/2022 | 371.31% | Keybanc | $24 → $23 | Maintains | Overweight |
| 04/22/2022 | 309.84% | Jefferies | $25 → $20 | Downgrades | Buy → Hold |
| 03/24/2022 | 371.31% | Truist Securities | $26 → $23 | Maintains | Hold |
| 03/11/2022 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 02/14/2022 | 432.79% | Credit Suisse | $27 → $26 | Maintains | Outperform |
| 02/01/2022 | — | Credit Suisse | Initiates Coverage On | → Outperform | |
| 01/03/2022 | 412.3% | Deutsche Bank | $27 → $25 | Downgrades | Buy → Hold |
| 10/29/2021 | 432.79% | Raymond James | $25 → $26 | Maintains | Strong Buy |
| 10/27/2021 | 391.8% | B of A Securities | $21.5 → $24 | Upgrades | Neutral → Buy |
| 10/26/2021 | 412.3% | Raymond James | → $25 | Initiates Coverage On | → Strong Buy |
| 08/11/2021 | 371.31% | RBC Capital | → $23 | Upgrades | Sector Perform → Outperform |
| 07/14/2021 | 371.31% | Mizuho | → $23 | Assumes | → Buy |
| 07/06/2021 | 340.57% | B of A Securities | → $21.5 | Downgrades | Buy → Neutral |
| 06/15/2021 | 371.31% | Wolfe Research | → $23 | Initiates Coverage On | → Peer Perform |
| 05/03/2021 | 371.31% | RBC Capital | $24 → $23 | Downgrades | Outperform → Sector Perform |
| 01/22/2021 | 350.82% | Truist Securities | → $22 | Downgrades | Buy → Hold |
| 01/21/2021 | 391.8% | KeyBanc | $22 → $24 | Maintains | Overweight |
| 12/15/2020 | 391.8% | Deutsche Bank | → $24 | Upgrades | Hold → Buy |
| 09/02/2020 | 330.33% | Stifel | → $21 | Reinstates | → Buy |
| 08/24/2020 | 371.31% | Mizuho | $20 → $23 | Upgrades | Neutral → Buy |
| 07/10/2020 | 289.34% | Deutsche Bank | $23 → $19 | Downgrades | Buy → Hold |
| 06/25/2020 | 309.84% | SunTrust Robinson Humphrey | $19 → $20 | Maintains | Buy |
| 04/23/2020 | 289.34% | SunTrust Robinson Humphrey | $22 → $19 | Maintains | Buy |
| 04/21/2020 | 309.84% | Keybanc | $25 → $20 | Maintains | Overweight |
| 04/03/2020 | 227.87% | Wells Fargo | $21 → $16 | Maintains | Equal-Weight |
| 04/03/2020 | 309.84% | JP Morgan | $25 → $20 | Maintains | Overweight |
| 03/30/2020 | 289.34% | Mizuho | → $19 | Downgrades | Buy → Neutral |
| 01/16/2020 | 371.31% | Keybanc | $22 → $23 | Maintains | Overweight |
| 01/14/2020 | 350.82% | Baird | $20 → $22 | Maintains | Neutral |
| 12/26/2019 | 432.79% | Mizuho | $25 → $26 | Maintains | Buy |
| 12/20/2019 | 412.3% | Mizuho | → $25 | Initiates Coverage On | → Buy |
| 10/14/2019 | 299.59% | B of A Securities | → $19.5 | Initiates Coverage On | → Neutral |
| 09/12/2019 | 350.82% | Berenberg | → $22 | Initiates Coverage On | → Buy |
| 09/03/2019 | 309.84% | Barclays | → $20 | Initiates Coverage On | → Overweight |
| 08/27/2019 | 330.33% | SunTrust Robinson Humphrey | $20 → $21 | Maintains | Buy |
| 08/07/2019 | 309.84% | Keybanc | → $20 | Upgrades | Sector Weight → Overweight |
| 07/24/2019 | 289.34% | Stifel | $18 → $19 | Upgrades | Hold → Buy |
| 07/02/2019 | 309.84% | SunTrust Robinson Humphrey | $19 → $20 | Upgrades | Hold → Buy |
| 03/29/2019 | 227.87% | Deutsche Bank | $14 → $16 | Maintains | Hold |
| 02/13/2019 | 371.31% | Jefferies | $18 → $23 | Upgrades | Hold → Buy |
| 12/11/2018 | 258.61% | Wells Fargo | $13.5 → $17.5 | Upgrades | Underperform → Market Perform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/16/2023 | -18.03% | 富国银行 | →$4 | 评级下调 | 等重→减码 |
| 09/25/2023 | 104.92% | 加拿大皇家银行资本 | →$10 | 重申 | 跑赢→跑赢大盘 |
| 2023年08月31日 | 84.43% | 瑞穗 | $18→$9 | 评级下调 | 购买→中性 |
| 2023年08月22日 | 104.92% | 巴克莱 | $12→$10 | 维护 | 超重 |
| 2023年08月21日 | 43.44% | 摩根大通 | $9→$7 | 评级下调 | 中性→减持 |
| 2023年08月14日 | 104.92% | 加拿大皇家银行资本 | $12→$10 | 维护 | 跑赢大盘 |
| 2023年08月11日 | 63.93% | B of A证券 | $9→$8 | 评级下调 | 中性→表现不佳 |
| 2023年08月11日 | - | 雷蒙德·詹姆斯 | 评级下调 | 强势买入→表现不佳 | |
| 2023/06/23 | 104.92% | Truist证券 | $9→$10 | 维护 | 保持 |
| 04/20/2023 | 84.43% | 富国银行 | →$9 | 开始承保 | →等重 |
| 04/19/2023 | 84.43% | 富国银行 | →$9 | 开始承保 | →等重 |
| 04/05/2023 | 145.9% | 巴克莱 | $14→$12 | 维护 | 超重 |
| 04/04/2023 | 207.38% | KeyBanc | $16→$15 | 维护 | 超重 |
| 03/31/2023 | 84.43% | Truist证券 | $8→$9 | 维护 | 保持 |
| 03/29/2023 | 63.93% | Truist证券 | $14→$8 | 维护 | 保持 |
| 03/16/2023 | 104.92% | B of A证券 | →$10 | 评级下调 | 购买→中性 |
| 03/07/2023 | 125.41% | 瑞士信贷 | →$11 | 重申 | →中性 |
| 03/03/2023 | 145.9% | 摩根大通 | $14→$12 | 维护 | 中性 |
| 03/02/2023 | 227.87% | 雷蒙德·詹姆斯 | $18→$16 | 维护 | 强势购买 |
| 02/27/2023 | 186.89% | 巴克莱 | $17→$14 | 维护 | 超重 |
| 02/24/2023 | 125.41% | 瑞士信贷 | $13→$11 | 维护 | 中性 |
| 2023年1月27日 | 248.36% | 巴克莱 | $19→$17 | 维护 | 超重 |
| 2023年1月19日 | 227.87% | KeyBanc | $18→$16 | 维护 | 超重 |
| 01/17/2023 | 166.39% | 瑞士信贷 | $11→$13 | 维护 | 中性 |
| 2022年12月21日 | 125.41% | 瑞士信贷 | $17→$11 | 维护 | 中性 |
| 2022年11月14日 | 227.87% | B of A证券 | →$16 | 升级 | 中性→购买 |
| 2022年10月21日 | 289.34% | 巴克莱 | $23→$19 | 维护 | 超重 |
| 10/04/2022 | 268.85% | 加拿大皇家银行资本 | $20→$18 | 维护 | 跑赢大盘 |
| 09/22/2022 | 268.85% | 雷蒙德·詹姆斯 | $20→$18 | 维护 | 强势购买 |
| 09/16/2022 | 207.38% | 德意志银行 | $17→$15 | 维护 | 保持 |
| 08/04/2022 | 371.31% | 巴克莱 | $27→$23 | 维护 | 超重 |
| 07/29/2022 | 309.84% | 瑞穗 | $26→$20 | 维护 | 买 |
| 07/15/2022 | 309.84% | 雷蒙德·詹姆斯 | $24→$20 | 维护 | 强势购买 |
| 07/14/2022 | 248.36% | 瑞士信贷 | $23→$17 | 评级下调 | 跑赢→中性 |
| 07/13/2022 | 248.36% | 德意志银行 | $20→$17 | 维护 | 保持 |
| 07/07/2022 | 268.85% | KeyBanc | $23→$18 | 维护 | 超重 |
| 2022/06/30 | 207.38% | 杰富瑞 | $19→$15 | 维护 | 保持 |
| 2022/06/22 | 268.85% | 摩根大通 | $24→$18 | 评级下调 | 超重→中性 |
| 05/20/2022 | 350.82% | 加拿大皇家银行资本 | $25→$22 | 维护 | 跑赢大盘 |
| 2022年05月10日 | 391.8% | 雷蒙德·詹姆斯 | $26→$24 | 维护 | 强势购买 |
| 05/02/2022 | 371.31% | 瑞士信贷 | $26→$23 | 维护 | 跑赢大盘 |
| 04/27/2022 | 309.84% | 德意志银行 | $25→$20 | 维护 | 保持 |
| 04/27/2022 | 371.31% | KeyBanc | $24→$23 | 维护 | 超重 |
| 04/22/2022 | 309.84% | 杰富瑞 | $25→$20 | 评级下调 | 购买→Hold |
| 03/24/2022 | 371.31% | Truist证券 | $26→$23 | 维护 | 保持 |
| 03/11/2022 | - | B of A证券 | 评级下调 | 购买→中性 | |
| 02/14/2022 | 432.79% | 瑞士信贷 | $27→$26 | 维护 | 跑赢大盘 |
| 02/01/2022 | - | 瑞士信贷 | 开始承保 | →跑赢大盘 | |
| 01/03/2022 | 412.3% | 德意志银行 | $27→$25 | 评级下调 | 购买→Hold |
| 10/29/2021 | 432.79% | 雷蒙德·詹姆斯 | $25→$26 | 维护 | 强势购买 |
| 10/27/2021 | 391.8% | B of A证券 | $21.5→$24 | 升级 | 中性→购买 |
| 10/26/2021 | 412.3% | 雷蒙德·詹姆斯 | →$25 | 开始承保 | →强势购买 |
| 2021/08/11 | 371.31% | 加拿大皇家银行资本 | →$23 | 升级 | 行业表现优于→ |
| 07/14/2021 | 371.31% | 瑞穗 | →$23 | 假设 | →购买 |
| 07/06/2021 | 340.57% | B of A证券 | →$21.5 | 评级下调 | 购买→中性 |
| 2021/06/15 | 371.31% | 沃尔夫研究 | →$23 | 开始承保 | →对等性能 |
| 05/03/2021 | 371.31% | 加拿大皇家银行资本 | $24→$23 | 评级下调 | 跑赢→板块表现 |
| 2021/01/22 | 350.82% | Truist证券 | →$22 | 评级下调 | 购买→Hold |
| 2021/01/21 | 391.8% | KeyBanc | $22→$24 | 维护 | 超重 |
| 12/15/2020 | 391.8% | 德意志银行 | →$24 | 升级 | 持有→购买 |
| 09/02/2020 | 330.33% | Stifel | →$21 | 恢复 | →购买 |
| 08/24/2020 | 371.31% | 瑞穗 | $20→$23 | 升级 | 中性→购买 |
| 07/10/2020 | 289.34% | 德意志银行 | $23→$19 | 评级下调 | 购买→Hold |
| 06/25/2020 | 309.84% | SunTrust Robinson Humphrey | $19→$20 | 维护 | 买 |
| 04/23/2020 | 289.34% | SunTrust Robinson Humphrey | $22→$19 | 维护 | 买 |
| 04/21/2020 | 309.84% | KeyBanc | $25→$20 | 维护 | 超重 |
| 04/03/2020 | 227.87% | 富国银行 | $21→$16 | 维护 | 等重 |
| 04/03/2020 | 309.84% | 摩根大通 | $25→$20 | 维护 | 超重 |
| 03/30/2020 | 289.34% | 瑞穗 | →$19 | 评级下调 | 购买→中性 |
| 1/16/2020 | 371.31% | KeyBanc | $22→$23 | 维护 | 超重 |
| 2020/01/14 | 350.82% | 贝尔德 | $20→$22 | 维护 | 中性 |
| 2019年12月26日 | 432.79% | 瑞穗 | $25→$26 | 维护 | 买 |
| 2019年12月20日 | 412.3% | 瑞穗 | →$25 | 开始承保 | →购买 |
| 2019年10月14日 | 299.59% | B of A证券 | →$19.5 | 开始承保 | →中性 |
| 2019/12/09 | 350.82% | 贝伦伯格 | →$22 | 开始承保 | →购买 |
| 2019年09月03日 | 309.84% | 巴克莱 | →$20 | 开始承保 | →超重 |
| 2019年08月27日 | 330.33% | SunTrust Robinson Humphrey | $20→$21 | 维护 | 买 |
| 2019年08月07日 | 309.84% | KeyBanc | →$20 | 升级 | 行业权重→超配 |
| 2019年07月24日 | 289.34% | Stifel | $18→$19 | 升级 | 持有→购买 |
| 2019年07月02日 | 309.84% | SunTrust Robinson Humphrey | $19→$20 | 升级 | 持有→购买 |
| 2019/03/29 | 227.87% | 德意志银行 | $14→$16 | 维护 | 保持 |
| 2019年02月13日 | 371.31% | 杰富瑞 | $18→$23 | 升级 | 持有→购买 |
| 2018年12月11日 | 258.61% | 富国银行 | $13.5→$17.5 | 升级 | 表现逊于→市场表现 |
What is the target price for Medical Properties Trust (MPW)?
医疗财产信托(MPW)的目标价是多少？
The latest price target for Medical Properties Trust (NYSE: MPW) was reported by Wells Fargo on October 16, 2023. The analyst firm set a price target for $4.00 expecting MPW to fall to within 12 months (a possible -18.03% downside). 27 analyst firms have reported ratings in the last year.
富国银行于2023年10月16日报道了医疗地产信托基金(纽约证券交易所代码：MPW)的最新目标价。这家分析公司将目标价定为4.00美元，预计MPW将在12个月内降至(可能下跌18.03%)。去年有27家分析公司公布了评级。
What is the most recent analyst rating for Medical Properties Trust (MPW)?
医疗地产信托基金(MPW)的最新分析师评级是多少？
The latest analyst rating for Medical Properties Trust (NYSE: MPW) was provided by Wells Fargo, and Medical Properties Trust downgraded their underweight rating.
医疗地产信托基金(纽约证券交易所代码：MPW)的最新分析师评级由富国银行提供，医疗地产信托基金下调了其减持评级。
When is the next analyst rating going to be posted or updated for Medical Properties Trust (MPW)?
医疗财产信托基金(MPW)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medical Properties Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medical Properties Trust was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与医疗地产信托的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。医疗财产信托的上一次评级是在2023年10月16日提交的，所以你应该预计下一次评级将在2024年10月16日左右提供。
Is the Analyst Rating Medical Properties Trust (MPW) correct?
分析师对医疗地产信托基金(MPW)的评级正确吗？
While ratings are subjective and will change, the latest Medical Properties Trust (MPW) rating was a downgraded with a price target of $0.00 to $4.00. The current price Medical Properties Trust (MPW) is trading at is $4.88, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的医疗财产信托(MPW)评级被下调，目标价为0.00美元至4.00美元。医疗地产信托公司(MPW)目前的交易价格为4.88美元，超出了分析师的预测范围。